Completed PHASE1 INTERVENTIONAL 4-arm NCT00468091

Effects of Exendin(9-39) on Gastroduodenal Motility

Regulation of Antro-pyloro-duodenal and Proximal Gastric Motility by GLP-1: Involvement of Cholinergic Pathways

Sponsor: German Research Foundation

Conditions Digestive Physiology Exendin (9-39) Gastrointestinal Hormones Gastrointestinal Motility Glucagon-like Peptide 1

Interventions atropine exendin(9-39)amide

Updated 6 times since 2017 Last updated: Mar 31, 2015 Started: Feb 28, 1999 Completion: Sep 30, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Digestive Physiology and Exendin (9-39), this trial is completed. The trial is conducted by German Research Foundation and has accumulated 6 data snapshots since 1999. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Dec 2024 — Present [monthly]

Completed PHASE1
Sep 2024 — Dec 2024 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Feb 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

German Research Foundation
Ludwig-Maximilians - University of Munich
Philipps University Marburg

Data source: Ludwig-Maximilians - University of Munich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany